Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Pain 9 Neoplasms 7 Agnosia 5 Multiple Myeloma 4 Hodgkin Disease 4 Pain, Postoperative 3 Lymphoma, Non-Hodgkin 3 Lymphoma 3 Lung Neoplasms 3 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 3 Leukemia 3 Hematologic Neoplasms 3 Head and Neck Neoplasms 3 Cancer Pain 3 Breast Neoplasms 3 Prostatic Neoplasms 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Philadelphia Chromosome 2 Neoplasm Metastasis 2 Myelodysplastic Syndromes 2 Melanoma 2 Lymphoma, Mantle-Cell 2 Lymphoma, B-Cell 2 Leukemia, Myeloid, Acute 2 Carcinoma in Situ 2 Burkitt Lymphoma 2 Acute Pain 2 Vulvar Neoplasms 1 Vulvar Diseases 1 Uterine Cervical Neoplasms 1

Interventions

Ketamine 2 substance P-saporin 1 Infusion Pumps, Implantable 1 Fentanyl 1 Dexmedetomidine 1 Acetaminophen 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Pain, Intractable × Acetaminophen × Clear all

NCT04096391 2022-05-18

Prosper-001

Evolve Restorative Center

Phase NA Completed

Pain, Intractable, Chronic Pain

Data powered by HemOnc (CC BY 4.0) Colophon ⚡